Professor of Neurology, Rush Medical College
Neurology
Dr. Christopher G. Goetz, MD
|
|
Give Review
Christopher G. Goetz, MD practices Neurology. He went to medical school at Rush Medical College. He has 4 awards "America's Top Doctors", "Chicago Magazine: Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Christopher Goetz is also published. He has 102 publications published. The lastest publication: "Clinimetric testing of the comprehensive cervical dystonia rating scale.'
Publications
- Parkinson's Disease-related fatigue: A case definition and recommendations for clinical research.
- Handling missing values in the MDS-UPDRS.
- Diagnosing PD-MCI by MDS task force criteria: How many and which neuropsychological tests?
- Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version.
- Comparison of the Movement Disorder Society Parkinson's Disease dementia criteria with neuropsychological testing.
- The past, present, and future of telemedicine for Parkinson's Disease.
- Are patients with Parkinson's Disease blind to blindsight?
- Using Cognitive Pretesting in Scale Development for Parkinson's Disease: The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Example.
- Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's Disease with hallucinations.
- A practical approach to remote longitudinal follow-up of Parkinson's Disease: The FOUND study.
- Babinski's contributions to cerebellar symptomatology: building the basis of the neurological examination.
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease: A Randomized Clinical Trial.
- Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments.
- Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's Disease.
- Continuous in-home monitoring of Essential tremor.
- Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's Disease.
- Task force report: Scales for screening and evaluating Tremor: Critique and recommendations.
- I finally see what you see: Parkinson's Disease visual hallucinations captured with functional neuroimaging.
- Diffusion tensor imaging of Parkinson's Disease, atypical parkinsonism, and essential tremor.
- Treating melancholia at home: theoretical wisdom and grim reality in the career of E.C. Seguin.
- Force control deficits in individuals with Parkinson's Disease, multiple systems atrophy, and progressive supranuclear palsy.
- The parkinson's Disease multidisciplinary package.
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's Disease rating scale: Comparison...
- Which Dyskinesia Scale Best Detects Treatment Response?
- Calibration of unified Parkinson's Disease rating scale scores to Movement Disorder Society-unified Parkinson's Disease rating scale scores.
- Clinical differences among mild cognitive impairment subtypes in Parkinson's Disease.
- Clinical validation of movement disorder society-recommended diagnostic criteria for Parkinson's Disease with dementia.
- Dopamine dysregulation Syndrome item from the MDS-UPDRS.
- Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's Disease.
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's Disease.
- Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's Disease.
- Temporal stability of the Unified Dyskinesia Rating Scale.
- The history of Parkinson's Disease: early clinical descriptions and neurological therapies.
- Wearing-off scales in Parkinson's Disease: Critique and recommendations.
- Visual plus nonvisual hallucinations in Parkinson's Disease: Development and evolution over 10 years.
- Health-related quality-of-life scales in Parkinson's Disease: Critique and recommendations.
- An update expert opinion on management and research strategies in Parkinson's Disease psychosis.
- The Movement disorders task force review of dysautonomia rating scales in Parkinson's Disease with regard to symptoms of orthostatic hypotension.
- The movement disorder society and movement Disorders: a modern history.
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's Disease hallucinations.
- Scales to assess sleep impairment in Parkinson's Disease: critique and recommendations.
- Hallucinations and sleep Disorders in PD: ten-year prospective longitudinal study.
- A 12-year population-based study of psychosis in Parkinson Disease.
- Association between antipsychotics and body mass index when treating patients with tics.
- Task force report on scales to assess dyskinesia in Parkinson's Disease: critique and recommendations.
- Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
- Missing pieces in the Parkinson's Disease puzzle.
- Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced Tremor.
- Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's Disease.
- New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's Disease.
- Jean-Martin Charcot and his vibratory chair for Parkinson Disease.
- Teaching program for the Unified Dyskinesia Rating Scale.
- Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily d...
- Determinants of quality of life in children with Gilles de la Tourette Syndrome.
- Dysautonomia rating scales in Parkinson's Disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating sca...
- Movement disorders caused by medical Disease.
- Testing objective measures of motor impairment in early Parkinson's Disease: Feasibility study of an at-home testing device.
- Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's Disease: a double blind video-based analysis.
- Comparison of tic characteristics between children and adults.
- The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
- Parkinson's Disease dementia: definitions, guidelines, and research perspectives in diagnosis.
- Effects of dopaminergic medications on psychosis and motor function in Dementia with Lewy bodies.
- Apathy and anhedonia rating scales in Parkinson's Disease: critique and recommendations.
- Anxiety rating scales in Parkinson's Disease: critique and recommendations.
- The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
- Antipsychotic medication treatment for mild hallucinations in Parkinson's Disease: Positive impact on long-term worsening.
- Evaluating Parkinson's Disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
- Placebo influences on dyskinesia in Parkinson's Disease.
- Scales to assess psychosis in Parkinson's Disease: Critique and recommendations.
- Concerning about the accuracy of data reported.
- Disclosure on author work effort.
- Levodopa-induced dyskinesias.
- J.-M. Charcot and simulated neurologic Disease: attitudes and diagnostic strategies.
- Depression rating scales in Parkinson's Disease: critique and recommendations.
- Contribution of Jules Froment to the study of parkinsonian rigidity.
- The etiopathogenesis of Parkinson Disease and suggestions for future research. Part II.
- The etiopathogenesis of Parkinson Disease and suggestions for future research. Part I.
- Author responsibilities and compliance with data source agreements.
- Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson Disease dementia.
- Sarizotan as a treatment for dyskinesias in Parkinson's Disease: a double-blind placebo-controlled trial.
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
- Neuropathic features in fragile X premutation carriers.
- Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's Disease.
- Early cinematographic studies of generalized Dystonia.
- Does seasonal variation affect hallucinations in PD? A longitudinal study.
- The malignant course of "benign hallucinations" in Parkinson Disease.
- Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's Disease patients.
- Gilles de la Tourette Syndrome: patient's knowledge and concern of adverse effects.
- Hallucinations in Parkinson Disease in the prelevodopa era.
- Movement Disorders associated with encephalitis lethargica: a video compilation.
- Rating scale for psychogenic movement Disorders: scale development and clinimetric testing.
- Transcultural comparison of psychogenic movement Disorders.
- Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's Disease: 2001 to 2004.
- Repeated visual hallucinations in Parkinson's Disease as disturbed external/internal perceptions: focused review and a new integrative model.
- Hallucinations and sleep Disorders in PD: six-year prospective longitudinal study.
- Fragile X-associated tremor/Ataxia syndrome in sisters related to X-inactivation.
- Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape.
- Genetic polymorphisms in Parkinson Disease subjects with and without hallucinations: an analysis of the cholecystokinin system.
- The origins of scientific cinematography and early medical applications.
- Clinimetric testing of the comprehensive cervical Dystonia rating scale.
Schools
Rush Medical College Of Rush University
Rush Presby St Lukes
Procedures Preformed
- EEG (Electroencephalogram)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Ataxia
- Cerebrovascular Disease
- Chorea (Excluding Huntington's Chorea)
- Corticobasal Degeneration
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Rush University Medical Center -
Rush Medical College
Hospital
-
Rush University Medical Center
Drug Facts
| NPI NUMBER | 1124004585 | |
| NPPES Provider LastName | GOETZ | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 606123824 | |
| NPPES Provider State | IL | |
| Specialty Description | Neurology | |
| Total Claim Count | 2178.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124004585 |
| Last Name Of The Provider | GOETZ |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
Dr. Nina A. Paleologos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Onur Melen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard L. Lipton, MD |
|
|
Dr. Neelum T. Aggarwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian J. Marcus, MD |
|
|
Dr. Yara Mikhaeil-Demo, MD |
|
|
Dr. Gian D. Pal, MD |
|
|
Dr. Korak Sarkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali Mansour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lakshmi Warrior, MD
This Doctor is OpenDoctor Recommended.
|